Jenny leads the global Evidence Review & Statistics team, which specializes in rigorous systematic literature reviews, indirect treatment comparisons, population-adjusted indirect comparisons, and modeling analytics. In addition, the team delivers targeted literature reviews and narrative synthesis to address focused, strategic evidence needs.
Jenny brings more than 20 years of research experience across academia and industry, partnering with pharmaceutical and MedTech clients to enable global launch planning and evidence generation across key markets, including the US, EU, UK, Canada, Japan, and China. Her work bridges methodological rigor with strategic insight to help clients leverage evidence review and synthesis to support payer, health technology assessment (HTA), and regulatory engagement. She also supports early assessments of comparative efficacy and safety to inform strategic planning.
Jenny has successfully delivered evidence generation projects across diverse therapeutic areas, including oncology, hematology, immunology, infectious diseases and vaccines, rare diseases, ophthalmology, psychiatry, cardiovascular disease, and neuromuscular disorders. She has co-authored more than 50 journal publications and conference abstracts, including work in leading medical journals.
Jenny received her PhD in Public Health research from New York University and completed postdoctoral training in Comparative Effectiveness and Decision Science at New York University School of Medicine. She also holds an MPH from the University of California, Los Angeles.